StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
genOway S.A.
Paris Stock Exchange:ALGEN.PA
Sector
Location
Market Cap
USD 34.41 M
Share Price
USD 3.55
Avg Daily Volume
3,232
Change (1 day)
-0.05%
Change (1 year)
-19.08%
Change (YTD)
-8.69%
genOway S.A. EBIT Margin for the year ending December 31, 2023: 10.30%
genOway S.A. EBIT Margin is 10.30% for the year ending December 31, 2023, a -197.65% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
genOway S.A. EBIT Margin for the year ending December 31, 2022 was -10.54%, a 5.48% change year over year.
-
genOway S.A. EBIT Margin for the year ending December 31, 2021 was -9.99%, a 165.03% change year over year.
-
genOway S.A. EBIT Margin for the year ending December 31, 2020 was -3.77%, a -6.37% change year over year.
-
genOway S.A. EBIT Margin for the year ending December 31, 2019 was -4.03%, a -69.41% change year over year.
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 132.20
MRK.DE
-0.95
-0.72%
Apogee Therapeutics, Inc.
USD 40.82
APGE
-0.82
-1.97%
PeptiDream Inc.
USD 11.59
4587.T
-0.04
-0.38%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Zoetis Inc.
USD 152.12
ZTS
-0.70
-0.46%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 132.20
MRK.DE
-0.95
-0.72%
Apogee Therapeutics, Inc.
USD 40.82
APGE
-0.82
-1.97%
PeptiDream Inc.
USD 11.59
4587.T
-0.04
-0.38%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Zoetis Inc.
USD 152.12
ZTS
-0.70
-0.46%